Corrigendum to ‘A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis)’ [Biomed. Pharmacother. 181 (2024) 117706] - 19/07/26
Doi : 10.1016/j.biopha.2026.119722
Qingliang Ge a, Tianqing Zhang a, Jiangbiao Yu a, Xuelin Lu a, Sijie Xiao b, Ting Zhang a, Tao Qing a, Zhenni Xiao a, Liuting Zeng c, Li Luo a, ⁎ 
a Department of Cardiology, Changde Hospital, Xiangya School of Medicine, Central South University (The first peoples hospital of Changde city), Changde City, China
b Department of Ultrasound, Changde Hospital, Xiangya School of Medicine, Central South University (The first peoples hospital of Changde city), Changde City, China
c Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
⁎ Corresponding author.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 201
Article 119722- août 2026 Retour au numéro
Article précédent
- Corrigendum: "Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments" [BIOPHA 176 (2024) 116808]
- Mohsen Nabi-Afjadi, Samane Ostadhadi, Mahsa Liaghat, Ajay Prakash Pasupulla, Sajjad Masoumi, Fatemeh Aziziyan, Hamidreza Zalpoor, Leila Abkhooie, Vahideh Tarhriz
- Corrigendum to “Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)” [Biomed. Pharmacother. 200 (2026), 119609]
- Saitong Muneekaew, Aussara Panya, Kritayaporn Saiprayong, Koollawat Chupradit, Thunchanok Nuchphongsai, Pasut Sasithong, Somsakul Pop Wongpalee, Natthanich Boonsatit, Methichit Wattanapanitch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?